Indoor cockroach insecticide aimed at reducing asthma triggers in underserved children
Official title: An indoor insecticide intervention to reduce allergen exposure and improve health outcomes for children with asthma in underserved communities
Funded at Nanometics, LLC · NIH-11409223 · Data updated 2026-11-12
A small NIH-funded project tests a new indoor insecticide product designed to reduce cockroach allergens and help children with asthma in underserved communities.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Nanometics, LLC NIH-funded |
| Lab location | 1 site (La Jolla, UNITED STATES) |
| Project start | August 5, 2026 |
| Project end | July 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $314,363 |
| NIH project number | 1R43MD021171-01A1 |
| Project ID | NIH-11409223 on NIH RePORTER |
Who could benefit from this research
✓Could help
Children aged 0-11 with asthma living in underserved communities where cockroach exposure is common.
✕Less likely to help
Children in areas with little cockroach exposure or asthma not linked to cockroach allergens may see no benefit.
What this research studies
This project explores a novel, consumer-friendly insecticide formulation that targets cockroach allergens linked to asthma flare-ups in underserved kids. It uses a unique, amorphous deltamethrin powder embedded in a common carrier to improve effectiveness against resistant cockroach populations. The goal is to see if reducing cockroach exposure can lessen asthma symptoms and healthcare use in this vulnerable group. By partnering with a real-world setting, the study aims to translate lab findings into a practical solution that families can access. The sponsor plans to monitor safety and any health outcomes to guide potential broader use if results are positive.
Why it matters
Potential benefit: If successful, children in underserved communities could experience fewer asthma symptoms and fewer urgent healthcare visits due to cockroach-related triggers.
How similar studies have gone: Prior studies and guidelines support cockroach reduction as a strategy to improve asthma outcomes, with ongoing work translating this into practical products.
Where this research is happening
-
Nanometics, LLC
La Jolla, United States Active
Researchers
- Principal investigator: Isaacman, Steven — Nanometics, LLC
- Study coordinator: Isaacman, Steven
Related research
Other NIH-funded projects on the same topics.
-
GLP-1 receptor agonists as immune targets to treat asthma in lean and obese adults
Aims to understand how GLP-1R‑agonist diabetes medicines may directly calm immune cells to reduce asthma in adults who are lean or obese.
-
Understanding how a type of immune cell called ILC2s affect asthma in adults
This grant studies how group 2 innate lymphoid cells influence asthma in adults to help identify new ways to manage airway inflammation.
-
Expanding understanding of asthma in kids through airways and blood profiling
A study at UC San Francisco will profile blood and nasal/sputum samples from 300 youth (including 200 with asthma) over a year to understand how environmental and social factors influence asthma in marginalized communities.
-
Preventing and improving asthma care for children in urban communities
This program will try several approaches — from giving helpful bacteria to babies to allergy immunotherapy and advanced airway testing — to prevent and better treat asthma in children who live in cities.
-
IDEAL project helps predict vaccine response, infections, and asthma in early childhood
A Child-focused program will collect and share saliva, blood, and tissue samples from diverse infants to find biological patterns that predict how vaccines work, how respiratory infections occur, and who develops asthma.
-
Understanding how early-life immune development affects vaccine responses and asthma risk in children
This project uses lab-grown human immune cells from infants and young children to explore why some kids respond poorly to vaccines and are more prone to respiratory infections and asthma.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.